Delivery Order SPE2DB20D2104-SPE2DB25FNBUT
Award Date 9/29/25
Potential Completion Date 9/30/25
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Zortress 0.25 mg tablets in unit dose packages of 60 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $6,831.73 and is scheduled for completion by August 25, 2025. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zortress 0.5 mg tablets in unit dose packaging (60-count) under a firm fixed-price contract valued at $9,306.29, with an ultimate completion date of August 15, 2025. This non-set-aside award represents a continuation of pharmaceutical supply support through AmerisourceBergen's existing relationship with DLA. The contractor will perform at its corporate office location in Conshohocken, Pennsylvania. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,361.61 firm fixed-price delivery order is for the supply of the immunosuppressant drug Zortress (everolimus) 0.5 mg tablets, with a completion date of December 3, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 14, 2025, by the Defense Logistics Agency's Medical Supply Chain for the supply of Everolimus 10 mg tablets (unit dose, 28-count packages) with a ceiling value of $1,358.26. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 25, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Everolimus 0.5 mg tablets in a quantity of 60 units. This is a firm fixed price delivery order with a ceiling value of $4,497.40 and an ultimate completion date of September 26, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Everolimus 0.25 mg tablets (60-count units) with a contract ceiling value of $1,800.00. This firm fixed-price delivery order represents a non-competitive award and is scheduled for completion by June 2, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 5, 2025, with a ceiling value of $1,933.80. The award covers the supply of Envarsus XR 0.75 mg tablets (100 count), a tacrolimus-based immunosuppressant medication used in transplant and autoimmune disease management. The contract is scheduled for completion by September 26, 2025, with...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Afinitor Disperz 3 mg tablets in quantities of 28 units. This competitively awarded, non-set-aside contract carries a ceiling value of $47,663.84 under firm fixed pricing terms, with an ultimate completion date of September 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a $12,778.22 firm fixed price delivery order to AmerisourceBergen Drug Corp for ATTRUBY 356 mg tablets (28-count packages) on April 24, 2025, with an ultimate completion date of May 15, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered...
- The Defense Logistics Agency awarded a $25,556.44 delivery order to AmerisourceBergen Drug Corp for Attruby 356 mg tablets (quantity: 28 units) on September 11, 2025, with an ultimate completion date of October 2, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...